Other Species / Isoforms
  PYCARD (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K21-ac
NLTAEELkkFKLKLL
0 7
PYCARD (human) NLTAEELkkFKLKLL K21-ac
PYCARD (mouse) NLSGDELkKFKMKLL K21-ac
PYCARD (rat) NLTADEFkkFKMkLL K21-ac
K21-ub
NLTAEELkkFKLKLL
0 2
PYCARD (human) NLTAEELkkFKLKLL K21-ub
PYCARD (mouse) NLSGDELKKFKMKLL K21
PYCARD (rat) NLTADEFKkFKMkLL K21
K22-ub
LTAEELkkFKLKLLS
0 2
PYCARD (human) LTAEELkkFKLKLLS K22-ub
PYCARD (mouse) LSGDELkKFKMKLLT K22
PYCARD (rat) LTADEFkKFKMkLLT K22
K22
LTAEELkKFKLKLLS
0 1
PYCARD (human) LTAEELkKFKLKLLS K22
PYCARD (mouse) LSGDELkKFKMKLLT K22
PYCARD (rat) LTADEFkkFKMkLLT K22-ac
K26
ELkkFKLKLLSVPLR
0 1
PYCARD (human) ELkkFKLKLLSVPLR K26
PYCARD (mouse) ELkKFKMKLLTVQLR K26
PYCARD (rat) EFkkFKMkLLTAPVR K26-ac
S46-p
IPRGALLsMDALDLT
0 2
PYCARD (human) IPRGALLsMDALDLT S46-p
PYCARD (mouse) IPRGALLQMDAIDLT Q46
PYCARD (rat) IPRGALLQMDPIDLT Q46
Y60-p
TDKLVSFyLETYGAE
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • signaling pathway regulation
Treatment
  • LPS
  • nigericin
  • PAO
PYCARD (human) TDKLVSFyLETYGAE Y60-p
PYCARD (mouse) TDKLVSYYLESYGLE Y60
PYCARD (rat) TDKLVSYYLEGYGLE Y60
K109-ub
APPQSAAkPGLHFID
Upstream
0 1
Treatment
  • MG132
PYCARD (human) APPQSAAkPGLHFID K109-ub
PYCARD (mouse) VPAQSTARTGHFVDQ R108
PYCARD (rat) VPAQGTARTEHFVDQ R108
Y137-p
EWLLDALyGkVLTDE
Upstream
Downstream
1 1
Effects on Modified Protein
  • activity, induced
Effects on Biological Processes:
  • signaling pathway regulation
Treatment
  • LPS
  • nigericin
  • PAO
PYCARD (human) EWLLDALyGkVLTDE Y137-p
PYCARD (mouse) DGVLDALHGSVLTEG H135
PYCARD (rat) DGLLDALYGNVLTEG Y135
K139-ub
LLDALyGkVLTDEQy
0 1
PYCARD (human) LLDALyGkVLTDEQy K139-ub
PYCARD (mouse) VLDALHGSVLTEGQy S137
PYCARD (rat) LLDALYGNVLTEGQY N137
Y146-p
kVLTDEQyQAVRAEP
Upstream
Downstream
3 6
Effects on Modified Protein
  • molecular association, regulation
Putative in vivo kinases:
  • Abl (human)
Treatment
  • ATP
  • GZD824
  • LPS
  • rebastinib
PYCARD (human) kVLTDEQyQAVRAEP Y146-p
PYCARD (mouse) SVLTEGQyQAVRAET Y144-p
PYCARD (rat) NVLTEGQYQAVRAET Y144
S164-p
SKMRKLFsFTPAWNW
0 1
PYCARD (human) SKMRKLFsFTPAWNW S164-p
PYCARD (mouse) DKMRKLFSFVPSWNL S162
PYCARD (rat) NKMRKLFSFAPAWNL S162
R182
DLLLQALRESQSYLV
0 1
PYCARD (human) DLLLQALRESQSYLV R182
PYCARD (mouse) DSLLQALkEIHPYLV K180-ub
PYCARD (rat) NLFLEALRQTQPYLV R180
S195-p
LVEDLERs_______
0 13
PYCARD (human) LVEDLERs_______ S195-p
PYCARD (mouse) LVMDLEQs_______ S193-p
PYCARD (rat) LVTDLEQs_______ S193-p